0001662223-18-000001.txt : 20180705 0001662223-18-000001.hdr.sgml : 20180705 20180705130829 ACCESSION NUMBER: 0001662223-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180705 DATE AS OF CHANGE: 20180705 EFFECTIVENESS DATE: 20180705 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Xios Therapeutics, Inc. CENTRAL INDEX KEY: 0001662223 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-316092 FILM NUMBER: 18940175 BUSINESS ADDRESS: STREET 1: C/O COOLEY LLP STREET 2: 500 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-937-2300 MAIL ADDRESS: STREET 1: C/O COOLEY LLP STREET 2: 500 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0708 D LIVE 0001662223 Xios Therapeutics, Inc. 100 Beaver Street Waltham MA MASSACHUSETTS 02453 617-937-2300 DELAWARE None None Corporation true 2015 Diala Ezzeddine 100 Beaver Street Waltham MA MASSACHUSETTS 02453 Executive Officer Director Jeff Bird 100 Beaver Street Waltham MA MASSACHUSETTS 02453 Director Rick Wagner 100 Beaver Street Waltham MA MASSACHUSETTS 02453 Director Other Decline to Disclose 06b false 2018-06-28 false true false 0 1500000 1000000 500000 false 21 0 0 0 false Xios Therapeutics, Inc. /s/ Diala Ezzeddine Diala Ezzeddine President 2018-07-05